Você pesquisou por y - Revista Brasileira de Ginecologia e Obstetrícia
You searched for:"Marcos de Lorenzo Messina"
We found (3) results for your search.Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2010;32(11):530-535
DOI 10.1590/S0100-72032010001100003
PURPOSE: to evaluate the effectiveness of uterine fibroid embolization (UFE) in patients with giant fibroids, with regard to both clinical outcomes and size reduction. METHODS: twenty-six patients with a mean age of 36.5 years, carrying symptomatic fibroids with a volume over 1,000 cm³, were referred for UFE. All patients had indication for percutaneous treatment. The procedures were performed under epidural anesthesia and sedation, using an institutional protocol. By unilateral femoral access, selective catheterization of uterine arteries and infusion of calibrated microspheres through microcatheter were carried out. Clinical evaluation was performed by means of regular outpatient gynecology consultation. All patients underwent magnetic resonance imaging (MRI) before the procedure and 15 patients underwent control MRI after 6 months. RESULTS: technical success was 100%. There was no complication related to the procedures. Mean uterine volume of the 15 patients studied was 1,401 cm³ before embolization (min 1,045 cm³, max 2,137 cm³) and 799 cm³ after 6 months (525 cm³ min, max. 1,604 cm³), resulting in a total reduction of 42.9%. Clinical improvement was observed in 25 of 26 patients. One woman with uterine volume of 1,098 cm³ who developed necrosis and partial fibroid expulsion underwent myomectomy. Another patient was submitted to myomectomy six months after the procedure because she wanted to become pregnant, despite partial fibroid size reduction. One patient with a uterine volume of 2,201 cm³ required a second intervention to achieve an adequate angiographic result. No patient underwent hysterectomy. On average, 9.2 microsphere syringes were used per patient. CONCLUSION: embolization of giant uterine fibroids is a feasible procedure with acceptable clinical and radiological outcomes. It can be considered an option for patients who desire to preserve the uterus, and it may serve as adjuvant therapy for high-risk myomectomy.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2010;32(11):530-535
DOI 10.1590/S0100-72032010001100003
PURPOSE: to evaluate the effectiveness of uterine fibroid embolization (UFE) in patients with giant fibroids, with regard to both clinical outcomes and size reduction. METHODS: twenty-six patients with a mean age of 36.5 years, carrying symptomatic fibroids with a volume over 1,000 cm³, were referred for UFE. All patients had indication for percutaneous treatment. The procedures were performed under epidural anesthesia and sedation, using an institutional protocol. By unilateral femoral access, selective catheterization of uterine arteries and infusion of calibrated microspheres through microcatheter were carried out. Clinical evaluation was performed by means of regular outpatient gynecology consultation. All patients underwent magnetic resonance imaging (MRI) before the procedure and 15 patients underwent control MRI after 6 months. RESULTS: technical success was 100%. There was no complication related to the procedures. Mean uterine volume of the 15 patients studied was 1,401 cm³ before embolization (min 1,045 cm³, max 2,137 cm³) and 799 cm³ after 6 months (525 cm³ min, max. 1,604 cm³), resulting in a total reduction of 42.9%. Clinical improvement was observed in 25 of 26 patients. One woman with uterine volume of 1,098 cm³ who developed necrosis and partial fibroid expulsion underwent myomectomy. Another patient was submitted to myomectomy six months after the procedure because she wanted to become pregnant, despite partial fibroid size reduction. One patient with a uterine volume of 2,201 cm³ required a second intervention to achieve an adequate angiographic result. No patient underwent hysterectomy. On average, 9.2 microsphere syringes were used per patient. CONCLUSION: embolization of giant uterine fibroids is a feasible procedure with acceptable clinical and radiological outcomes. It can be considered an option for patients who desire to preserve the uterus, and it may serve as adjuvant therapy for high-risk myomectomy.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2010;32(2):77-81
DOI 10.1590/S0100-72032010000200005
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2010;32(2):77-81
DOI 10.1590/S0100-72032010000200005
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2001;23(9):597-602
DOI 10.1590/S0100-72032001000900008
Purpose: to evaluate the results of uterine artery embolization (UAE) in the treatment of uterine leiomyomas. Methods: eighteen patients with ultrasonographic diagnosis of uterine leiomyomas were submitted to UAE with polyvinyl alcohol (PVA) particles. The femoral arteries are the access sites until selective catheterization of the uterine arteries. Imaging regarding uterine volume was performed before the procedure and three months after wards. Clinical follow-up was performed at regular intervals after the procedure to assess patient menstrual characteristics and uterine volume. Results: three procedures were technically unsuccessful because of failure of superselective catheterization. Control of menorrhagia and pelvic pain was reported at three months after the procedure by 86 and 60% of patients, respectively. The initial mean uterine volume was 381 cm³ and after 3 months, 263 cm³. The mean uterine volume reduction was 27.4% after three months of follow-up. Clinical and biochemical findings consistent with ovarian failure were observed in three (20%) patients. Conclusions: UAE represents a new therapeutic approach in the treatment of uterine leiomyomas. The risk of ovarian failure after the procedure limits its use to patients aged 45 years or without pregnancy wish.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2001;23(9):597-602
DOI 10.1590/S0100-72032001000900008
Purpose: to evaluate the results of uterine artery embolization (UAE) in the treatment of uterine leiomyomas. Methods: eighteen patients with ultrasonographic diagnosis of uterine leiomyomas were submitted to UAE with polyvinyl alcohol (PVA) particles. The femoral arteries are the access sites until selective catheterization of the uterine arteries. Imaging regarding uterine volume was performed before the procedure and three months after wards. Clinical follow-up was performed at regular intervals after the procedure to assess patient menstrual characteristics and uterine volume. Results: three procedures were technically unsuccessful because of failure of superselective catheterization. Control of menorrhagia and pelvic pain was reported at three months after the procedure by 86 and 60% of patients, respectively. The initial mean uterine volume was 381 cm³ and after 3 months, 263 cm³. The mean uterine volume reduction was 27.4% after three months of follow-up. Clinical and biochemical findings consistent with ovarian failure were observed in three (20%) patients. Conclusions: UAE represents a new therapeutic approach in the treatment of uterine leiomyomas. The risk of ovarian failure after the procedure limits its use to patients aged 45 years or without pregnancy wish.
